Sacyl Pharmaceuticals
UEI: P7PTTL5ABBZ5
• CAGE: 9S4K1
Overview
Awardee Type
Parent
Company Description
Sacyl Pharmaceuticals, a biotech startup in the New York Metropolitan Area,
aims to develop non-hormonal, fast-acting on-demand contraceptives as a
first male contraceptive and as a safe contraception option for women.
Sacyl's program is based on inhibitiors of soluble adenylyl cyclase, an
enzyme regulating sperm activation and motility.
Name
Sacyl Pharmaceuticals
Website
Headquarters
Old Greenwich, CT
United States
United States
Most Recent Award
Sept. 22, 2025
Calculating
Federal grant recipient
SACYL PHARMACEUTICALS, INC.
(UEI P7PTTL5ABBZ5, CAGE 9S4K1)
is headquartered in Old Greenwich CT.
Its primary registered NAICS is 325412 Pharmaceutical Preparation Manufacturing.
The corporation
was founded in August 2022 and
federally registered in
November 2023.
Federal Award Analysis
Sacyl Pharmaceuticals federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
Legal Name
SACYL PHARMACEUTICALS, INC.
UEI
P7PTTL5ABBZ5
CAGE Code
9S4K1
Primary NAICS
SBA Certifications
None
Self Certifications
Self-Certified Small Disadvantaged Business
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Contracts and Assistance
Date Founded
Aug. 13, 2022
Initial Registration
Nov. 28, 2023
Last Registration
Oct. 17, 2025
Registration Activation
Oct. 17, 2025
Registration Expiration
Oct. 15, 2026
Fiscal Year End
December 31
Reported Entity Types
For Profit Organization
State of Incorporation
DE
Country of Incorporation
USA
Employees
<500
Reported NAICS
Accepts Credit Cards
No